Breaking News Instant updates and real-time market news.

RXDX

Ignyta

$13.25

0.1 (0.76%)

04:55
10/06/17
10/06
04:55
10/06/17
04:55

Ignyta management to meet with JPMorgan

Meetings to be held in Boston on October 5 and in New York on October 6 hosted by JPMorgan.

  • 06

    Oct

  • 06

    Nov

RXDX Ignyta
$13.25

0.1 (0.76%)

01/05/17
JEFF
01/05/17
NO CHANGE
JEFF
Celgene, Alkermes among Jefferies' top 2017 Biotech picks
Jefferies' Biotechnology equity research team laid out their top picks for 2017. Following a volatile two years, the biotech space seeks to achieve "greater equilibrium" in 2017, the analysts write in a research note. They cite increasing competition, slowing volumes, and ramping payer leverage as reasons to remain selective when picking stocks this year and beyond. Among large-caps, Jefferies likes Celgene (CELG) for its "best-in-class growth" and sees limited downside in Gilead (GILD) shares. In the mid-cap space, the firm favors Alkermes (ALKS) given the prospects for Vivitrol and Aristada and a "strong" neurology pipeline as well as Vertex (VRTX). Jefferies' top small-cap picks include Aevi Genomics Medicine, Alder Biopharmaceuticals (ALDR), AMAG Pharmaceuticals (AMAG), DBV Technologies (DBVT), Immunomedics (IMMU), Ignyta (RXDX), Karyopharm (KPTI), RA Pharmaceuticals (RARX), TherapeuticsMD (TXMD) and Xenon Pharmaceuticals (XENE).
05/15/17
LTCO
05/15/17
NO CHANGE
Target $20
LTCO
Buy
Ignyta breakthrough designation cuts Loxo's time-to-market edge, says Ladenburg
Ladenburg Thalmann analyst Kevin DeGeeter said Ignyta (RXDX) being granted Breakthrough Therapy Designation for entrectinib puts the drug on level footing with Loxo Oncology's (LOXO) larotrectinib for a six-month FDA review for a TRK indication, effectively reducing Loxo's potential time-to-market advantage by 4 months. Thalmann said he has more comfort now that Ignyta should meet its goal of launching entrectinib in the first half of 2019, with potential upside of a late 2018 launch, and thinks the BTD may "lift a cloud" as some investors wondered if the FDA viewed larotrectinib as a better drug. He maintains a Buy rating and $20 price target on Ignyta shares.
05/15/17
PIPR
05/15/17
NO CHANGE
PIPR
Overweight
Ignyta breakthrough designation 'levels the field' with Loxo, says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer said one of the key investor concerns regarding Ignyta's (RXDX) entrectinib has been a lack of breakthrough designation in patients with NTRK fusions, which was read as perhaps suggesting an "inferior" profile to Loxo Oncology's (LOXO) larotrectrinib. News that the FDA granted entrectinib the designation "levels the playing field" and should help ease investor concerns, said Schimmer, who keeps an Overweight rating on Ignyta shares.
08/17/17
JPMS
08/17/17
NO CHANGE
JPMS
JPMorgan lists top SMID Biotechnology picks following Q2 results
Analysts at JPMorgan continue think selectively remains important in the small-to-mid cap Biotechnology space. The analysts listed their favorite ideas in "five key buckets." Amicus (FOLD) is the top long-term pick, Ironwood (IRWD) is the top pick among relative underperformers, Otonomy (OTIC) is the top play for a clinical/binary event, Sarepta (SRPT) is the name to take advantage of the recent share weakness, and Ignyta (RXDX) is the "underfollowed/undervalued" favorite, according to JPMorgan's Biotech team.

TODAY'S FREE FLY STORIES

RDWR

Radware

$21.09

-0.25 (-1.17%)

10:01
02/21/18
02/21
10:01
02/21/18
10:01
Conference/Events
Radware management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 29

    Mar

QTWO

Q2 Holdings

$42.85

-1.8 (-4.03%)

10:00
02/21/18
02/21
10:00
02/21/18
10:00
Conference/Events
Q2 Holdings management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 15

    Mar

10:00
02/21/18
02/21
10:00
02/21/18
10:00
General news
U.S. Markit manufacturing PMI rose 0.4 points to 55.9 in the flash February »

U.S. Markit manufacturing…

LFUS

Littelfuse

$208.66

0.61 (0.29%)

09:59
02/21/18
02/21
09:59
02/21/18
09:59
Conference/Events
Littelfuse management to meet with Oppenheimer »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

NJDCY

Nidec

$37.80

-0.12 (-0.32%)

09:57
02/21/18
02/21
09:57
02/21/18
09:57
Conference/Events
Nidec management to meet with Oppenheimer »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

HDP

Hortonworks

$18.22

0.03 (0.16%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Conference/Events
Hortonworks management to meet with Northland »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 26

    Feb

  • 11

    Mar

  • 13

    Mar

  • 14

    Mar

  • 11

    Apr

  • 30

    May

PVG

Pretium Resources

$6.56

-0.05 (-0.76%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Options
Pretium Resources put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

  • 11

    Mar

AAP

Advance Auto Parts

$115.88

10.53 (10.00%)

, EXR

Extra Space Storage

$84.86

4.105 (5.08%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Options
Early notable gainers among liquid option names on February 21st »

Notable gainers among…

AAP

Advance Auto Parts

$115.88

10.53 (10.00%)

EXR

Extra Space Storage

$84.86

4.105 (5.08%)

MOS

Mosaic

$27.48

0.72 (2.69%)

CF

CF Industries

$42.80

0.975 (2.33%)

VRSK

Verisk Analytics

$97.04

-1.75 (-1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 30

    May

GVA

Granite Construction

$60.01

0.0066 (0.01%)

09:52
02/21/18
02/21
09:52
02/21/18
09:52
Conference/Events
Granite Construction management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 23

    May

CPS

Cooper-Standard

$120.74

-0.8988 (-0.74%)

09:51
02/21/18
02/21
09:51
02/21/18
09:51
Conference/Events
Cooper-Standard management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

LEXEB

Liberty Expedia Holdings

09:50
02/21/18
02/21
09:50
02/21/18
09:50
Hot Stocks
Breaking Hot Stocks news story on Liberty Expedia Holdings  »

Liberty Expedia Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANET

Arista Networks

$249.53

-0.125 (-0.05%)

09:50
02/21/18
02/21
09:50
02/21/18
09:50
Conference/Events
Arista Networks management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 26

    Feb

  • 06

    Mar

  • 13

    Mar

  • 14

    Mar

  • 29

    Mar

LEXEB

Liberty Expedia Holdings

09:45
02/21/18
02/21
09:45
02/21/18
09:45
Hot Stocks
Breaking Hot Stocks news story on Liberty Expedia Holdings  »

Liberty Expedia Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
02/21/18
02/21
09:45
02/21/18
09:45
General news
Existing Home Sales to be reported at 10:00 »

January Existing Home…

PM

Philip Morris

09:43
02/21/18
02/21
09:43
02/21/18
09:43
Earnings
Philip Morris sees Q1 EPS about 87c, including 3c of favorable currency 

Consensus is 90c.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVAX

Dynavax

$17.25

0.025 (0.15%)

09:41
02/21/18
02/21
09:41
02/21/18
09:41
Hot Stocks
Dynavax says CDC advisory committee recommends Heplisav-B »

Dynavax announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 04

    Apr

GRMN

Garmin

$64.86

-0.35 (-0.54%)

, DUST

Direxion Daily Gold Miners Bear 3X ETF

09:40
02/21/18
02/21
09:40
02/21/18
09:40
Options
Unusually active option classes on open February 21st »

Unusual total active…

GRMN

Garmin

$64.86

-0.35 (-0.54%)

DUST

Direxion Daily Gold Miners Bear 3X ETF

STZ

Constellation Brands, also tag STZ.B

PEP

PepsiCo

$109.48

-1.58 (-1.42%)

XRT

S&P Retail Index SPDR

P

Pandora

GM

General Motors

MA

MasterCard

NXPI

NXP Semiconductors

$125.56

7.06 (5.96%)

MCD

McDonald's

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 23

    Feb

  • 26

    Feb

  • 01

    Mar

  • 05

    Mar

  • 08

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

  • 30

    May

DKS

Dick's Sporting

09:38
02/21/18
02/21
09:38
02/21/18
09:38
Upgrade
Dick's Sporting rating change  »

Dick's Sporting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:35
02/21/18
02/21
09:35
02/21/18
09:35
General news
Treasury 5-year auction outlook: the $35 B sale is the second leg »

Treasury 5-year auction…

LJPC

La Jolla

$33.17

-0.7 (-2.07%)

09:35
02/21/18
02/21
09:35
02/21/18
09:35
Hot Stocks
La Jolla announces treatment of first patient in Giapreza pediatric study »

La Jolla Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

FNF

FNF Group

09:34
02/21/18
02/21
09:34
02/21/18
09:34
Recommendations
FNF Group analyst commentary  »

FNF Group added to Top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMSC

AMSC

$4.71

0.1 (2.17%)

09:33
02/21/18
02/21
09:33
02/21/18
09:33
Hot Stocks
AMSC announces $10M in D-VAR system orders »

AMSC announced three new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

EXPE

Expedia

$104.10

0.25 (0.24%)

09:32
02/21/18
02/21
09:32
02/21/18
09:32
Recommendations
Expedia analyst commentary  »

Expedia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 07

    Mar

09:30
02/21/18
02/21
09:30
02/21/18
09:30
General news
PMI Composite Flash Manufacturing â€' Level to be reported at 09:45 »

February PMI Composite…

09:30
02/21/18
02/21
09:30
02/21/18
09:30
General news
PMI Composite Flash â€' Level to be reported at 09:45 »

February PMI Composite…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.